SIX1 and breast carcinoma: Recently, some studies have shown that overexpression of Six1 facilitates the metastasis of breast cancer through TGF-β signaling, epithelial-mesenchymal transition [21], and inducing lymphangiogenesis via upregulation of VEGF-C [22].